Global Hemoperfusion Sales Market Report 2024
The global Hemoperfusion market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemoperfusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hepatic Encephalopathy occupies the largest market share of Hepatic Encephalopathy and is the fastest growing
The Hemoperfusion market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Hemoperfusion market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
Table of Content
1 Hemoperfusion Market Overview
1.1 Hemoperfusion Product Scope
1.2 Hemoperfusion Segment by Type
1.2.1 Global Hemoperfusion Sales by Type (2016 & 2021 & 2027)
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Hemoperfusion Segment by Application
1.3.1 Global Hemoperfusion Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hepatic Encephalopathy
1.3.3 Certain Autoimmune Diseases
1.3.4 Drug Overdose
1.3.5 Specific Intoxications
1.3.6 Others
1.4 Hemoperfusion Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hemoperfusion Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hemoperfusion Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hemoperfusion Price Trends (2016-2027)
2 Hemoperfusion Estimates and Forecasts by Region
2.1 Global Hemoperfusion Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hemoperfusion Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hemoperfusion Sales Market Share by Region (2016-2021)
2.2.2 Global Hemoperfusion Revenue Market Share by Region (2016-2021)
2.3 Global Hemoperfusion Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hemoperfusion Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hemoperfusion Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hemoperfusion Estimates and Projections (2016-2027)
2.4.2 Europe Hemoperfusion Estimates and Projections (2016-2027)
2.4.3 China Hemoperfusion Estimates and Projections (2016-2027)
2.4.4 Japan Hemoperfusion Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hemoperfusion Estimates and Projections (2016-2027)
2.4.6 India Hemoperfusion Estimates and Projections (2016-2027)
3 Global Hemoperfusion Competition Landscape by Players
3.1 Global Top Hemoperfusion Players by Sales (2016-2021)
3.2 Global Top Hemoperfusion Players by Revenue (2016-2021)
3.3 Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemoperfusion as of 2020)
3.4 Global Hemoperfusion Average Price by Company (2016-2021)
3.5 Manufacturers Hemoperfusion Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hemoperfusion Market Size by Type
4.1 Global Hemoperfusion Historic Market Review by Type (2016-2021)
4.1.1 Global Hemoperfusion Sales Market Share by Type (2016-2021)
4.1.2 Global Hemoperfusion Revenue Market Share by Type (2016-2021)
4.1.3 Global Hemoperfusion Price by Type (2016-2021)
4.2 Global Hemoperfusion Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hemoperfusion Sales Forecast by Type (2022-2027)
4.2.2 Global Hemoperfusion Revenue Forecast by Type (2022-2027)
4.2.3 Global Hemoperfusion Price Forecast by Type (2022-2027)
5 Global Hemoperfusion Market Size by Application
5.1 Global Hemoperfusion Historic Market Review by Application (2016-2021)
5.1.1 Global Hemoperfusion Sales Market Share by Application (2016-2021)
5.1.2 Global Hemoperfusion Revenue Market Share by Application (2016-2021)
5.1.3 Global Hemoperfusion Price by Application (2016-2021)
5.2 Global Hemoperfusion Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hemoperfusion Sales Forecast by Application (2022-2027)
5.2.2 Global Hemoperfusion Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemoperfusion Price Forecast by Application (2022-2027)
6 North America Hemoperfusion Market Facts & Figures
6.1 North America Hemoperfusion Sales by Company
6.1.1 North America Hemoperfusion Sales by Company (2016-2021)
6.1.2 North America Hemoperfusion Revenue by Company (2016-2021)
6.2 North America Hemoperfusion Sales Breakdown by Type
6.2.1 North America Hemoperfusion Sales Breakdown by Type (2016-2021)
6.2.2 North America Hemoperfusion Sales Breakdown by Type (2022-2027)
6.3 North America Hemoperfusion Sales Breakdown by Application
6.3.1 North America Hemoperfusion Sales Breakdown by Application (2016-2021)
6.3.2 North America Hemoperfusion Sales Breakdown by Application (2022-2027)
7 Europe Hemoperfusion Market Facts & Figures
7.1 Europe Hemoperfusion Sales by Company
7.1.1 Europe Hemoperfusion Sales by Company (2016-2021)
7.1.2 Europe Hemoperfusion Revenue by Company (2016-2021)
7.2 Europe Hemoperfusion Sales Breakdown by Type
7.2.1 Europe Hemoperfusion Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hemoperfusion Sales Breakdown by Type (2022-2027)
7.3 Europe Hemoperfusion Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Hemoperfusion Market Facts & Figures
8.1 China Hemoperfusion Sales by Company
8.1.1 China Hemoperfusion Sales by Company (2016-2021)
8.1.2 China Hemoperfusion Revenue by Company (2016-2021)
8.2 China Hemoperfusion Sales Breakdown by Type
8.2.1 China Hemoperfusion Sales Breakdown by Type (2016-2021)
8.2.2 China Hemoperfusion Sales Breakdown by Type (2022-2027)
8.3 China Hemoperfusion Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Hemoperfusion Market Facts & Figures
9.1 Japan Hemoperfusion Sales by Company
9.1.1 Japan Hemoperfusion Sales by Company (2016-2021)
9.1.2 Japan Hemoperfusion Revenue by Company (2016-2021)
9.2 Japan Hemoperfusion Sales Breakdown by Type
9.2.1 Japan Hemoperfusion Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hemoperfusion Sales Breakdown by Type (2022-2027)
9.3 Japan Hemoperfusion Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hemoperfusion Market Facts & Figures
10.1 Southeast Asia Hemoperfusion Sales by Company
10.1.1 Southeast Asia Hemoperfusion Sales by Company (2016-2021)
10.1.2 Southeast Asia Hemoperfusion Revenue by Company (2016-2021)
10.2 Southeast Asia Hemoperfusion Sales Breakdown by Type
10.2.1 Southeast Asia Hemoperfusion Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hemoperfusion Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hemoperfusion Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hemoperfusion Market Facts & Figures
11.1 India Hemoperfusion Sales by Company
11.1.1 India Hemoperfusion Sales by Company (2016-2021)
11.1.2 India Hemoperfusion Revenue by Company (2016-2021)
11.2 India Hemoperfusion Sales Breakdown by Type
11.2.1 India Hemoperfusion Sales Breakdown by Type (2016-2021)
11.2.2 India Hemoperfusion Sales Breakdown by Type (2022-2027)
11.3 India Hemoperfusion Sales Breakdown by Application
11.3.1 India Hemoperfusion Sales Breakdown by Application (2016-2021)
11.3.2 India Hemoperfusion Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hemoperfusion Business
12.1 Jafron Biomedical
12.1.1 Jafron Biomedical Corporation Information
12.1.2 Jafron Biomedical Business Overview
12.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jafron Biomedical Hemoperfusion Products Offered
12.1.5 Jafron Biomedical Recent Development
12.2 Baxter (Gambro)
12.2.1 Baxter (Gambro) Corporation Information
12.2.2 Baxter (Gambro) Business Overview
12.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter (Gambro) Hemoperfusion Products Offered
12.2.5 Baxter (Gambro) Recent Development
12.3 Asahi-Kasei
12.3.1 Asahi-Kasei Corporation Information
12.3.2 Asahi-Kasei Business Overview
12.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Asahi-Kasei Hemoperfusion Products Offered
12.3.5 Asahi-Kasei Recent Development
12.4 Biosun Medical
12.4.1 Biosun Medical Corporation Information
12.4.2 Biosun Medical Business Overview
12.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biosun Medical Hemoperfusion Products Offered
12.4.5 Biosun Medical Recent Development
12.5 Kaneka
12.5.1 Kaneka Corporation Information
12.5.2 Kaneka Business Overview
12.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kaneka Hemoperfusion Products Offered
12.5.5 Kaneka Recent Development
12.6 Toray Medical
12.6.1 Toray Medical Corporation Information
12.6.2 Toray Medical Business Overview
12.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Toray Medical Hemoperfusion Products Offered
12.6.5 Toray Medical Recent Development
12.7 Cytosorbents
12.7.1 Cytosorbents Corporation Information
12.7.2 Cytosorbents Business Overview
12.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cytosorbents Hemoperfusion Products Offered
12.7.5 Cytosorbents Recent Development
12.8 Aier
12.8.1 Aier Corporation Information
12.8.2 Aier Business Overview
12.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aier Hemoperfusion Products Offered
12.8.5 Aier Recent Development
12.9 Zibo Kangbei
12.9.1 Zibo Kangbei Corporation Information
12.9.2 Zibo Kangbei Business Overview
12.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zibo Kangbei Hemoperfusion Products Offered
12.9.5 Zibo Kangbei Recent Development
13 Hemoperfusion Manufacturing Cost Analysis
13.1 Hemoperfusion Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hemoperfusion
13.4 Hemoperfusion Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hemoperfusion Distributors List
14.3 Hemoperfusion Customers
15 Market Dynamics
15.1 Hemoperfusion Market Trends
15.2 Hemoperfusion Drivers
15.3 Hemoperfusion Market Challenges
15.4 Hemoperfusion Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer